TICKERNERD
Menu
PATHPATHTechnology · Software - Infrastructure

PATH Stock Forecast: UiPath, Inc. Price Predictions for 2026-2027

Last close, 2 Oct 2026
$13
−1.58% on the day

The 21 Wall Street analysts covering UiPath, Inc. hold a median 12-month price target of $15 — +14.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 81 of 100 as at 1 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$6.9B
Ticker Nerd rank
81 / 100
Median analyst target
$15
Analysts covering
21
Revenue$410.3M+13.4% y/y
Operating income$31.6M
Net income$36.1M
Free cash flow$29.3M
Quarterly, 8 quarters to 31 July 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+5.2%
1M
−27.1%
YTD
−20.0%
1Y
+2.8%
From 52W high
−32.0%
From 52W low
+39.8%
$9
$19
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PATH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores UiPath, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Oct 2026
81 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
82
Growth
81
Momentum
79
Issuance
78
Value
78
Revisions
75
Accruals
32
Volatility
28
Size
18

Quality (82): The business earns solid, repeatable profits on what it owns.

Volatility (28): The share price moves around a lot.

Size (18): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PATH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PATH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20Jan 26Apr 26Jul 26Oct 26PATHHigh $23Median $15Low $10

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says21 analysts
3 Buy16 Hold2 Sell
Low $10Median $15High $23

The green dot is the last close — the median target sits +14.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 7 moved it down.

DateFirmActionRatingTarget
28 Sept 2026DA DavidsonDowngradeUnderperform$10
25 Sept 2026UBSMaintainsNeutral$15 → $14
24 Sept 2026BMO CapitalMaintainsMarket Perform$18 → $15
24 Sept 2026Canaccord GenuityMaintainsHold$17 → $14
24 Sept 2026TD CowenMaintainsHold$16 → $15
23 Sept 2026NeedhamReiteratesBuy$22
23 Sept 2026RBC CapitalMaintainsSector Perform$17 → $15
23 Sept 2026TD CowenReiteratesHold$16
23 Sept 2026Truist SecuritiesMaintainsHold$17 → $14
23 Sept 2026UBSMaintainsNeutral$19 → $15
8 Sept 2026CitigroupInitiatesBuy$23
8 Sept 2026CitigroupInitiatesBuy—
4 Sept 2026B of A SecuritiesMaintainsUnderperform$13 → $15
4 Sept 2026B of A SecuritiesMaintainsUnderperform—
4 Sept 2026BarclaysMaintainsEqual-Weight$14 → $17
4 Sept 2026BarclaysMaintainsEqual-Weight—
4 Sept 2026BMO CapitalMaintainsMarket Perform—
4 Sept 2026BMO CapitalMaintainsMarket Perform$13 → $18
4 Sept 2026Canaccord GenuityDowngradeHold—
4 Sept 2026Canaccord GenuityDowngradeHold$15 → $17

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PATH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

PATH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, UiPath, Inc. returned +2.8% against +15.4% for the S&P 500, dividends included.

PATH vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140160Jan 26Apr 26Jul 26Oct 26PATHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PATH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.2%
Analysts raising
9
Analysts cutting
4
Fundamentals

UiPath, Inc. (PATH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
19.0×

Cheaper than 38% of US stocks

Price / sales
4.0×

Cheaper than 30% of US stocks

Price / book
3.6×

Cheaper than 27% of US stocks

EV / EBITDA
31.1×

Cheaper than 8% of US stocks

Growth & margins
Revenue growth (YoY)
13.4%

Higher than 60% of US stocks

Earnings growth (YoY)
2178.3%

Higher than 99% of US stocks

Gross margin
80.4%

Higher than 91% of US stocks

Operating margin
8.9%

Higher than 62% of US stocks

Net margin
21.0%

Higher than 83% of US stocks

Returns & dividend
Return on equity
20.0%

Higher than 81% of US stocks

Return on assets
3.7%

Higher than 69% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

UiPath, Inc. (PATH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • UiPath, Inc. has a market value of $6.9B and an enterprise value of $5.7B.

  • Revenue in the twelve months to 31 July 2026: $1.7B. The latest quarter grew 13.4% year on year.

  • Net income over the same four quarters: $361.9M, a 21.0% net margin.

  • Diluted earnings per share, trailing twelve months: $0.67.

  • Free cash flow in the twelve months to 31 July 2026: $363.0M.

  • UiPath, Inc. spent $268.5M on share buybacks in the twelve months to 31 July 2026.

  • Shares outstanding: 521.0M.

  • Trailing P/E: 19.0×; forward P/E: 14.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • UiPath, Inc. employs 3,981 people — $432K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 July 2026 · market figures as at 2 Oct 2026

Data provided by Twelve Data

Peers

PATH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Infrastructure
CompanyMarket capTKN rank
PATHUiPath, Inc.$6.9B
81
NTSKNetskope, Inc.$7.0B
25
DBXDropbox, Inc.$7.4B
83
QLYSQualys, Inc.$6.5B
94
DOXAmdocs Ltd.$6.3B
64
ZETAZeta Global Holdings Corp.$8.1B
69
SSentinelOne, Inc.$8.4B
50

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own UiPath, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PATH news & analysis

UiPath: AI Orchestration Leader With Deep-Value Price Tag - Reiterate Buy

Seeking Alpha · 1 Oct 2026positive

Seeking Alpha highlights UiPath's expanded code-building, agent-mapping, and orchestration capabilities, describing the company as an AI orchestration leader with a vertically integrated Agentic AI platform. The article notes raised FY2027 guidance and long-term profitable growth targets tied to an expected Agentic AI market expansion to $142B by 2030.

Why it matters — A PATH watcher would care because the article underscores UiPath's positioning in the growing Agentic AI market and points to raised guidance and growth targets as factors tied to its share price.

UiPath Joins NCQA AI Learning Collaborative to Advance Responsible AI in Healthcare

Business Wire · 1 Oct 2026positive

UiPath has announced it will join the National Committee for Quality Assurance's (NCQA) AI Learning Collaborative for Prior Authorization to support responsible AI in healthcare. The initiative focuses on advancing AI practices in healthcare prior-authorization processes.

Why it matters — A PATH watcher would care because this collaboration signals UiPath's expansion into healthcare AI applications, potentially opening new adoption opportunities for its automation platforms.

UiPath: Large Account Growth Is Compelling

Seeking Alpha · 1 Oct 2026positive

A Seeking Alpha article highlights UiPath's strong enterprise demand and upmarket momentum, noting the company raised its FY26 revenue guidance to $1.789–$1.794B (11% year-over-year growth) while improving profitability, with pro forma operating margin reaching 22%. Net revenue retention stands at 109%, with accelerating large-customer growth and AI central to top deals.

Why it matters — PATH watchers would care because the report indicates both accelerating large-account growth and improved profitability, suggesting the company's enterprise and AI strategy is gaining traction.

UiPath: Worth Picking Up At This Price (Rating Upgrade)

Seeking Alpha · 1 Oct 2026positive

Seeking Alpha upgraded UiPath to a buy, arguing that its current valuation appears overly pessimistic given projected TAM growth through 2030 and recent innovations in coding agents and orchestration. While ARR and revenue growth are sluggish, large customer spending and net retention rates remain solid, reflecting mixed but partly resilient demand.

Why it matters — PATH watchers would care because the upgrade signals that a major analyst sees upside potential, framing recent sluggish growth as a temporary valuation concern rather than a fundamental decline, while highlighting long-term market expansion and product innovation.

UiPath vs. Zeta Global: Which AI Stock Is the Better Buy?

Zacks Investment Research · 30 Sept 2026positive

A Zacks Investment Research article compares UiPath and Zeta Global as AI stock investments, concluding that UiPath edges out Zeta Global on valuation and enterprise AI momentum. The article highlights agentic automation adoption and workflow orchestration as factors broadening UiPath's growth opportunity.

Why it matters — For PATH watchers, this piece offers a favorable comparison that positions UiPath ahead of a rival on valuation and enterprise AI momentum, reinforcing the company's growth narrative.

FAQ

Frequently asked questions about PATH stock

What is the PATH stock price forecast for 2026-2027?

The 21 Wall Street analysts covering UiPath, Inc. have a median 12-month price target of $15, with estimates ranging from $10 to $23. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PATH stock a buy right now?

Of the 21 analysts covering UiPath, Inc., 3 rate it a Buy, 16 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks UiPath, Inc. 81 out of 100 across roughly 4,600 US stocks as at 1 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PATH?

As at 1 Oct 2026, UiPath, Inc. ranks 81 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (82 of 100).

Will PATH stock go up?

No one can know that. What the data says: the median 12-month target from 21 analysts implies +14.4% from the last close, and Ticker Nerd's factor model ranks UiPath, Inc. 81 out of 100 as at 1 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PATH stock forecast for 2030?

No analyst covering UiPath, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PATH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $23 over the next 12 months.

How has PATH stock performed over the past year?

UiPath, Inc. returned +2.8% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does UiPath, Inc. do?

UiPath, Inc. Class A Common Stock represents ownership in UiPath, Inc., a software company focused on automation and orchestration for modern enterprises.

What is the latest news on PATH?

The most recent item we track (Seeking Alpha, 1 Oct 2026): "UiPath: AI Orchestration Leader With Deep-Value Price Tag - Reiterate Buy". Seeking Alpha highlights UiPath's expanded code-building, agent-mapping, and orchestration capabilities, describing the company as an AI orchestration leader with a vertically integrated Agentic AI platform. The article notes raised FY2027 guidance and long-term profitable growth targets tied to an expected Agentic AI market expansion to $142B by 2030.

Company

About UiPath, Inc.

UiPath, Inc. Class A Common Stock represents ownership in UiPath, Inc., a software company focused on automation and orchestration for modern enterprises. UiPath provides an integrated automation platform that helps organizations coordinate AI agents, robots, people, and models within shared workflows. Its product suite includes robotic process automation, process orchestration and intelligence, agent building tools, API automation, intelligent document processing, test automation, and governance capabilities. The platform is used across industries such as financial services, healthcare, manufacturing, retail, and the public sector to streamline repetitive processes and connect work across applications and teams. Founded in 2005 and headquartered in New York, UiPath is positioned as a significant provider of enterprise automation software for businesses seeking to improve operational consistency and scalability.

CEO Mr. Daniel Solomon Dines · 3,981 employees · United States · https://www.uipath.com